Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis (Q35925484)

11 August 2017

1 reference

title

Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis (English)

1 reference

11 August 2017

Sheila A Doggrell

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

Expert Opinion on Pharmacotherapy

11 August 2017

published in

1 reference

11 August 2017

volume

5

1 reference

11 August 2017

issue

11

1 reference

11 August 2017

page(s)

2209-2220

1 reference

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Effectiveness of the sirolimus-eluting stent in the treatment of patients with a prior history of coronary artery bypass graft surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Inhibition of smooth muscle cell proliferation after local drug delivery of the antimitotic drug paclitaxel using a porous balloon catheter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Pathological analysis of local delivery of paclitaxel via a polymer-coated stent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Local drug delivery via a coronary stent with programmable release pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Novel drug-delivery stent: intravascular ultrasound observations from the first human experience with the QP2-eluting polymer stent system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

A paclitaxel-eluting stent for the prevention of coronary restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2209

10.1517/14656566.5.11.2209

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference